Alessandro Muzzi
Alessandro Muzzi has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Claudio Donati
Unit of Computational Biology, Research and Innovation Centre, Fondazione Edmund Mach
3 shared publications - Antonello Covacci
Novartis Vaccines and Diagnostics, Via Fiorentina 1, 53100 Siena, Italy
2 shared publications - David R. Riley
Institute for Genome Sciences, Department of Microbiology and Immunology, University of Maryland School of Medicine, 801 West Baltimore Street, MD 21201, USA
2 shared publications - E. Richard Moxon
Department of Paediatrics, University of Oxford, Oxford, United Kingdom
2 shared publications - Fen Ze Hu
Allegheny General Hospital, Allegheny-Singer Research Institute, Center for Genomic Sciences, Pittsburgh, Pennsylvania 152123, USA
2 shared publications - Garth D. Ehrlich
Center for Genomic Sciences, Institute for Molecular Medicine and Infectious Disease and Department of Microbiology & Immunology, Drexel University College of Medicine, Philadelphia, Pennsylvania, USA
2 shared publications
Latest Publications
- Open Access
- 1 January 2014
- Published by Springer Nature in BMC Microbiology
- Vol. 14 (1) , 111
Diversity of greek meningococcal serogroup B isolates and estimated coverage of the 4CMenB meningococcal vaccine
Serogroup B meningococcal (MenB) isolates currently account for approximately 90% of invasive meningococcal disease (IMD) in Greece with ST-162 clonal complex predominating. The potential of a multicomponent meningococcal B vaccine (4CMenB) recently licensed in Europe was investigated in order to find whether the aforementioned vaccine will cover the MenB strains circulating in Greece. A panel of 148 serogroup B invasive meningococcal strains was characterized by multilocus sequence typing (MLST) and PorA subtyping. Vaccine components were typed by sequencing for factor H-binding protein (fHbp), Neisserial Heparin Binding Antigen (NHBA) and Neisseria adhesin A (NadA). Their expression was explored by Meningococcal Antigen Typing System (MATS).
- 1 January 2014
- Published by Springer Nature in BMC Microbiology
- Vol. 14 (1) , 111
Open AccessDiversity of greek meningococcal serogroup B isolates and estimated coverage of the 4CMenB meningococcal vaccine
Serogroup B meningococcal (MenB) isolates currently account for approximately 90% of invasive meningococcal disease (IMD) in Greece with ST-162 clonal complex predominating. The potential of a multicomponent meningococcal B vaccine (4CMenB) recently licensed in Europe was investigated in order to find whether the aforementioned vaccine will cover the MenB strains circulating in Greece. A panel of 148 serogroup B invasive meningococcal strains was characterized by multilocus sequence typing (MLST) and PorA subtyping. Vaccine components were typed by sequencing for factor H-binding protein (fHbp), Neisserial Heparin Binding Antigen (NHBA) and Neisseria adhesin A (NadA). Their expression was explored by Meningococcal Antigen Typing System (MATS).
- Open Access
- 1 July 2013
- Published by American Society for Microbiology in mBio
- Vol. 4 (3) , e00163-13-13
Conservation of Meningococcal Antigens in the Genus Neisseria
Neisseria meningitidis , one of the major causes of bacterial meningitis and sepsis, is a member of the genus Neisseria , which includes species that colonize the mucosae of many animals. Three meningococcal proteins, factor H-binding protein (fHbp), neisserial heparin-binding antigen (NHBA), and N. meningitidis adhesin A (NadA), have been described as antigens protective against N. meningitidis of serogroup B, and they have been employed as vaccine components in preclinical and clinical studies. In the vaccine formulation, fHbp and NHBA were fused to the GNA2091 and GNA1030 proteins, respectively, to enhance protein stability and immunogenicity. To determine the possible impact of vaccination on commensal neisseriae, we determined the presence, distribution, and conservation of these antigens in the available genome sequences of the genus Neisseria , finding that fHbp, NHBA, and NadA were conserved only in species colonizing humans, while GNA1030 and GNA2091 were conserved in many human and nonhuman neisseriae. Sequence analysis showed that homologous recombination contributed to shape the evolution and distribution of both NHBA and fHbp, three major variants of which have been defined. fHbp variant 3 was probably the ancestral form of meningococcal fHbp, while fHbp variant 1 from N. cinerea was introduced into N. meningitidis by a recombination event. fHbp variant 2 was the result of a recombination event inserting a stretch of 483 bp from variant 1 into the variant 3 background. These data indicate that a high rate of exchange of genetic material between neisseriae that colonize the human upper respiratory tract exists. IMPORTANCE The upper respiratory tract of healthy individuals is a complex ecosystem colonized by many bacterial species. Among these, there are representatives of the genus Neisseria , including Neisseria meningitidis , a major cause of bacterial meningitis and sepsis. Given the close relationship between commensal and pathogenic species, a protein-based vaccine against N. meningitidis has the potential to impact the other commensal species of Neisseria . For this reason, we have studied the distribution and evolutionary history of the antigen components of a recombinant vaccine, 4CMenB, that recently received approval in Europe under the commercial name of Bexsero®. We found that fHbp, NHBA, and NadA can be found in some of the human commensal species and that the evolution of these antigens has been essentially shaped by the high rate of genetic exchange that occurs between strains of neisseriae that cocolonize the same environment.
- 1 July 2013
- Published by American Society for Microbiology in mBio
- Vol. 4 (3) , e00163-13-13
Open AccessConservation of Meningococcal Antigens in the Genus Neisseria
Neisseria meningitidis , one of the major causes of bacterial meningitis and sepsis, is a member of the genus Neisseria , which includes species that colonize the mucosae of many animals. Three meningococcal proteins, factor H-binding protein (fHbp), neisserial heparin-binding antigen (NHBA), and N. meningitidis adhesin A (NadA), have been described as antigens protective against N. meningitidis of serogroup B, and they have been employed as vaccine components in preclinical and clinical studies. In the vaccine formulation, fHbp and NHBA were fused to the GNA2091 and GNA1030 proteins, respectively, to enhance protein stability and immunogenicity. To determine the possible impact of vaccination on commensal neisseriae, we determined the presence, distribution, and conservation of these antigens in the available genome sequences of the genus Neisseria , finding that fHbp, NHBA, and NadA were conserved only in species colonizing humans, while GNA1030 and GNA2091 were conserved in many human and nonhuman neisseriae. Sequence analysis showed that homologous recombination contributed to shape the evolution and distribution of both NHBA and fHbp, three major variants of which have been defined. fHbp variant 3 was probably the ancestral form of meningococcal fHbp, while fHbp variant 1 from N. cinerea was introduced into N. meningitidis by a recombination event. fHbp variant 2 was the result of a recombination event inserting a stretch of 483 bp from variant 1 into the variant 3 background. These data indicate that a high rate of exchange of genetic material between neisseriae that colonize the human upper respiratory tract exists. IMPORTANCE The upper respiratory tract of healthy individuals is a complex ecosystem colonized by many bacterial species. Among these, there are representatives of the genus Neisseria , including Neisseria meningitidis , a major cause of bacterial meningitis and sepsis. Given the close relationship between commensal and pathogenic species, a protein-based vaccine against N. meningitidis has the potential to impact the other commensal species of Neisseria . For this reason, we have studied the distribution and evolutionary history of the antigen components of a recombinant vaccine, 4CMenB, that recently received approval in Europe under the commercial name of Bexsero®. We found that fHbp, NHBA, and NadA can be found in some of the human commensal species and that the evolution of these antigens has been essentially shaped by the high rate of genetic exchange that occurs between strains of neisseriae that cocolonize the same environment.
- 15 November 2012
- Published by American Society for Microbiology in Journal of Bacteriology
- Vol. 194 (22) , 6217-6232
Analysis of the Regulated Transcriptome of Neisseria meningitidis in Human Blood Using a Tiling Array
Neisseria meningitidisis the major cause of septicemia and meningococcal meningitis. During the course of infection, the bacterium must adapt to different host environments as a crucial factor for survival and dissemination; in particular, one of the crucial factors inN. meningitidispathogenesis is the ability to grow and survive in human blood. We recently showed thatN. meningitidisalters the expression of 30% of the open reading frames (ORFs) of the genome during incubation in human whole blood and suggested the presence of fine regulation at the gene expression level in order to control this step of pathogenesis. In this work, we used a customized tiling oligonucleotide microarray to define the changes in the whole transcriptional profile ofN. meningitidisin a time course experiment ofex vivobacteremia by incubating bacteria in human whole blood and then recovering RNA at different time points. The application of a newly developed bioinformatic tool to the tiling array data set allowed the identification of new transcripts—small intergenic RNAs,cis-encoded antisense RNAs, mRNAs with extended 5′ and 3′ untranslated regions (UTRs), and operons—differentially expressed in human blood. Here, we report a panel of expressed small RNAs, some of which can potentially regulate genes involved in bacterial metabolism, and we show, for the first time inN. meningitidis, extensive antisense transcription activity. This analysis suggests the presence of a circuit of regulatory RNA elements used byN. meningitidisto adapt to proliferate in human blood that is worthy of further investigation.
- 15 November 2012
- Published by American Society for Microbiology in Journal of Bacteriology
- Vol. 194 (22) , 6217-6232
Analysis of the Regulated Transcriptome of Neisseria meningitidis in Human Blood Using a Tiling Array
Neisseria meningitidisis the major cause of septicemia and meningococcal meningitis. During the course of infection, the bacterium must adapt to different host environments as a crucial factor for survival and dissemination; in particular, one of the crucial factors inN. meningitidispathogenesis is the ability to grow and survive in human blood. We recently showed thatN. meningitidisalters the expression of 30% of the open reading frames (ORFs) of the genome during incubation in human whole blood and suggested the presence of fine regulation at the gene expression level in order to control this step of pathogenesis. In this work, we used a customized tiling oligonucleotide microarray to define the changes in the whole transcriptional profile ofN. meningitidisin a time course experiment ofex vivobacteremia by incubating bacteria in human whole blood and then recovering RNA at different time points. The application of a newly developed bioinformatic tool to the tiling array data set allowed the identification of new transcripts—small intergenic RNAs,cis-encoded antisense RNAs, mRNAs with extended 5′ and 3′ untranslated regions (UTRs), and operons—differentially expressed in human blood. Here, we report a panel of expressed small RNAs, some of which can potentially regulate genes involved in bacterial metabolism, and we show, for the first time inN. meningitidis, extensive antisense transcription activity. This analysis suggests the presence of a circuit of regulatory RNA elements used byN. meningitidisto adapt to proliferate in human blood that is worthy of further investigation.
- Open Access
- 1 January 2011
- Published by Springer Nature in Genome Biology
- Vol. 12 (10) , 140
Correction: Structure and dynamics of the pan-genome of Streptococcus pneumoniae and closely related species
- 1 January 2011
- Published by Springer Nature in Genome Biology
- Vol. 12 (10) , 140
Open AccessCorrection: Structure and dynamics of the pan-genome of Streptococcus pneumoniae and closely related species
- Open Access
- 29 October 2010
- Published by Springer Nature in Genome Biology
- Vol. 11 (10) , R107
Structure and dynamics of the pan-genome of Streptococcus pneumoniae and closely related species
Streptococcus pneumoniae is one of the most important causes of microbial diseases in humans. The genomes of 44 diverse strains of S. pneumoniae were analyzed and compared with strains of non-pathogenic streptococci of the Mitis group.
- 29 October 2010
- Published by Springer Nature in Genome Biology
- Vol. 11 (10) , R107
Open AccessStructure and dynamics of the pan-genome of Streptococcus pneumoniae and closely related species
Streptococcus pneumoniae is one of the most important causes of microbial diseases in humans. The genomes of 44 diverse strains of S. pneumoniae were analyzed and compared with strains of non-pathogenic streptococci of the Mitis group.